Global and China Solid Tumors Drugs Market Research Report Forecast 2017 to 2022

July 2017 | 119 pages | ID: G9AFED21BA2EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The Global and China Solid Tumors Drugs Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Solid Tumors Drugs industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Solid Tumors Drugs market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Global and China Solid Tumors Drugs Market: Regional Segment Analysis

Global
China

The Major players reported in the market include:

Hoffmann-La Roche
Novartis
Celgene
Johnson & Johnson
Pfizer
BMS
AbbVie
AbGenomics
ADC Therapeutics

Global and China Solid Tumors Drugs Market: Product Segment Analysis

• Type 1
• Type 2
• Type 3

Global and China Solid Tumors Drugs Market: Application Segment Analysis

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 SOLID TUMORS DRUGS MARKET OVERVIEW

1.1 Solid Tumors Drugs Definition
1.2 Solid Tumors Drugs Classification and Application
1.3 Solid Tumors Drugs Industry Chain
1.4 Solid Tumors Drugs Industry Overview

CHAPTER 2 GLOBAL AND CHINA ECONOMIC IMPACT ON SOLID TUMORS DRUGS INDUSTRY

2.1 Global Macroeconomic Environment Analysis
2.2 China Macroeconomic Environment Analysis

CHAPTER 3 GLOBAL SOLID TUMORS DRUGS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

3.1 Global Solid Tumors Drugs Market Competition by Manufacturers
  3.1.1 Global Solid Tumors Drugs Production and Market Share of Key Manufacturers (2012-2017)
  3.1.2 Global Solid Tumors Drugs Revenue and Share by Manufacturers (2012-2017)
3.2 Global Solid Tumors Drugs Production and Revenue by Type
  3.3.1 Global Solid Tumors Drugs Production and Market Share by Type (2012-2017)
  3.3.2 Global Solid Tumors Drugs Revenue and Market Share by Type (2012-2017)
3.3 Global Solid Tumors Drugs Production and Revenue by Application

CHAPTER 4 CHINA SOLID TUMORS DRUGS MARKET ANALYSIS

4.1 China Solid Tumors Drugs Production and Revenue (2012-2017)
  4.1.1 China Solid Tumors Drugs Production and Growth Rate (2012-2017)
  4.1.2 China Solid Tumors Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 China Solid Tumors Drugs Sales Price Trend (2012-2017)
4.2 China Solid Tumors Drugs Production and Market Share by Manufacturers
4.3 China Solid Tumors Drugs Production and Market Share by Type
4.4 China Solid Tumors Drugs Production and Market Share by Application

CHAPTER 5 GLOBAL SOLID TUMORS DRUGS MANUFACTURERS ANALYSIS

5.1 Hoffmann-La Roche
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Product Type, Application and Specification
  5.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.1.4 Business Overview
5.2 Novartis
  5.2.1 Company Basic Information, Manufacturing Base and Competitors
  5.2.2 Product Type, Application and Specification
  5.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.2.4 Business Overview
5.3 Celgene
  5.3.1 Company Basic Information, Manufacturing Base and Competitors
  5.3.2 Product Type, Application and Specification
  5.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.3.4 Business Overview
5.4 Johnson & Johnson
  5.4.1 Company Basic Information, Manufacturing Base and Competitors
  5.4.2 Product Type, Application and Specification
  5.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.4.4 Business Overview
5.5 Pfizer
  5.5.1 Company Basic Information, Manufacturing Base and Competitors
  5.5.2 Product Type, Application and Specification
  5.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.5.4 Business Overview
5.6 BMS
  5.6.1 Company Basic Information, Manufacturing Base and Competitors
  5.6.2 Product Type, Application and Specification
  5.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.6.4 Business Overview
5.7 AbbVie
  5.7.1 Company Basic Information, Manufacturing Base and Competitors
  5.7.2 Product Type, Application and Specification
  5.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.7.4 Business Overview
5.8 AbGenomics
  5.8.1 Company Basic Information, Manufacturing Base and Competitors
  5.8.2 Product Type, Application and Specification
  5.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.8.4 Business Overview
5.9 ADC Therapeutics
  5.9.1 Company Basic Information, Manufacturing Base and Competitors
  5.9.2 Product Type, Application and Specification
  5.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.9.4 Business Overview

CHAPTER 6 SOLID TUMORS DRUGS MANUFACTURING COST ANALYSIS

6.1 Solid Tumors Drugs Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Solid Tumors Drugs

CHAPTER 7 MARKET EFFECT FACTORS ANALYSIS

7.1 Technology Progress/Risk
  7.1.1 Substitutes Threat
  7.1.2 Technology Progress in Related Industry
7.2 Consumer Needs/Customer Preference Change
7.3 Economic/Political Environmental Change

CHAPTER 8 GLOBAL SOLID TUMORS DRUGS MARKET FORECAST (2017-2022)

8.1 Global Solid Tumors Drugs Production, Revenue Forecast (2017-2022)
8.2 Global Solid Tumors Drugs Production Forecast by Type (2017-2022)
8.3 Global Solid Tumors Drugs Consumption Forecast by Application (2017-2022)
8.4 China Solid Tumors Drugs Production, Consumption Forecast by Regions (2017-2022)
8.5 Solid Tumors Drugs Price Forecast (2017-2022)

CHAPTER 9 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Solid Tumors Drugs
Figure Global Production Market Share of Solid Tumors Drugs by Type in 2016
Table Solid Tumors Drugs Consumption Market Share by Application in 2016
Table Global Solid Tumors Drugs Capacity of Key Manufacturers (2015 and 2016)
Table Global Solid Tumors Drugs Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Solid Tumors Drugs Capacity of Key Manufacturers in 2015
Figure Global Solid Tumors Drugs Capacity of Key Manufacturers in 2016
Table Global Solid Tumors Drugs Production of Key Manufacturers (2015 and 2016)
Table Global Solid Tumors Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Solid Tumors Drugs Production Share by Manufacturers
Figure 2016 Solid Tumors Drugs Production Share by Manufacturers
Table Global Solid Tumors Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Solid Tumors Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Solid Tumors Drugs Revenue Share by Manufacturers
Table 2016 Global Solid Tumors Drugs Revenue Share by Manufacturers
Table Global Market Solid Tumors Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Solid Tumors Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Solid Tumors Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Solid Tumors Drugs Product Type
Figure Solid Tumors Drugs Market Share of Top 3 Manufacturers
Figure Solid Tumors Drugs Market Share of Top 5 Manufacturers
Table Global Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table China Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Solid Tumors Drugs Production by Type (2012-2017)
Table Global Solid Tumors Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Solid Tumors Drugs by Type (2012-2017)
Figure 2015 Production Market Share of Solid Tumors Drugs by Type
Table Global Solid Tumors Drugs Revenue by Type (2012-2017)
Table Global Solid Tumors Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Solid Tumors Drugs by Type (2012-2017)
Figure 2015 Revenue Market Share of Solid Tumors Drugs by Type
Table Global Solid Tumors Drugs Price by Type (2012-2017)
Figure Global Solid Tumors Drugs Production Growth by Type (2012-2017)
Table Global Solid Tumors Drugs Consumption by Application (2012-2017)
Table Global Solid Tumors Drugs Consumption Market Share by Application (2012-2017)
Figure Global Solid Tumors Drugs Consumption Market Share by Application in 2016
Table Global Solid Tumors Drugs Consumption Growth Rate by Application (2012-2017)
Figure Global Solid Tumors Drugs Consumption Growth Rate by Application (2012-2017)
Figure China Solid Tumors Drugs Production and Growth Rate (2012-2017)
Figure China Solid Tumors Drugs Revenue and Growth Rate (2012-2017)
Figure China Solid Tumors Drugs Production Price Trend (2012-2017)
Table China Solid Tumors Drugs Production by Manufacturers (2012-2017)
Table China Solid Tumors Drugs Market Share by Manufacturers (2012-2017)
Table China Solid Tumors Drugs Production by Type (2012-2017)
Table China Solid Tumors Drugs Market Share by Type (2012-2017)
Table China Solid Tumors Drugs Production by Application (2012-2017)
Table China Solid Tumors Drugs Market Share by Application (2012-2017)
Table Hoffmann-La Roche Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Hoffmann-La Roche Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Hoffmann-La Roche Solid Tumors Drugs Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Solid Tumors Drugs Market Share (2012-2017)
Table Celgene Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Celgene Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Celgene Solid Tumors Drugs Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Johnson & Johnson Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Johnson & Johnson Solid Tumors Drugs Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Solid Tumors Drugs Market Share (2012-2017)
Table BMS Basic Information, Manufacturing Base, Production Area and Its Competitors
Table BMS Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table BMS Solid Tumors Drugs Market Share (2012-2017)
Table AbbVie Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AbbVie Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table AbbVie Solid Tumors Drugs Market Share (2012-2017)
Table AbGenomics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AbGenomics Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table AbGenomics Solid Tumors Drugs Market Share (2012-2017)
Table ADC Therapeutics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table ADC Therapeutics Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table ADC Therapeutics Solid Tumors Drugs Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Solid Tumors Drugs
Figure Manufacturing Process Analysis of Solid Tumors Drugs
Figure Solid Tumors Drugs Industrial Chain Analysis
Table Raw Materials Sources of Solid Tumors Drugs Major Manufacturers in 2016
Table Major Buyers of Solid Tumors Drugs
Table Distributors/Traders List
Figure Global Solid Tumors Drugs Production and Growth Rate Forecast (2017-2022)
Figure Global Solid Tumors Drugs Revenue and Growth Rate Forecast (2017-2022)
Table Global Solid Tumors Drugs Production Forecast by Type (2017-2022)
Table Global Solid Tumors Drugs Consumption Forecast by Application (2017-2022)
Table China Solid Tumors Drugs Production and Consumption Forecast by Regions (2017-2022)